Cracking The Code: Understanding Analyst Reviews For Biogen
Cracking The Code: Understanding Analyst Reviews For Biogen
破譯密碼：理解渤健公司的分析師評論
An in-depth analysis of recent analyst actions unveils how financial experts perceive Biogen. The following summary...During the last three months, 20 analysts shared their evaluations of Biogen (NASDAQ:BIIB), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，20位分析師分享了他們對Biogen（納斯達克股票代碼：BIIB）的評估，揭示了從看漲到看跌的不同前景。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Biogen, revealing an average target of $281.45, a high estimate of $317.00, and a low estimate of $190.00. This current average represents a 2.31% decrease from the previous average price target of $288.11.
分析師已經爲Biogen設定了12個月的目標股價，顯示平均目標股價爲281.45美元，最高估計爲317.00美元，最低估計爲190.00美元。目前的平均價格比之前的288.11美元的平均目標股價下降了2.31％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
An in-depth analysis of recent analyst actions unveils how financial experts perceive Biogen. The following summary...
對分析師近期行爲的深入分析揭示了金...
登入免費觀看全文
登入/註冊